Senseonics Holdings, Inc. (SENS)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Diabetes Products and Services	35.26M	22.47M	22.39M	16.39M	13.68M
Diabetes Products and Services Growth	56.89%	0.37%	36.62%	19.85%	176.32%
Total	35.26M	22.47M	22.39M	16.39M	13.68M
Total Growth	56.89%	0.37%	36.62%	19.85%	176.32%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	27.91M	15.28M	14.05M	7.51M	2.56M
United States Growth	82.67%	8.72%	87.07%	193.67%	126.77%
outside of The United States	7.35M	7.19M	8.34M	8.88M	11.12M
outside of The United States Growth	2.14%	-13.71%	-6.08%	-20.15%	190.94%
Total	35.26M	22.47M	22.39M	16.39M	13.68M
Total Growth	56.89%	0.37%	36.62%	19.85%	176.32%

Data Source: S&P Global Market Intelligence Last updated: Mar 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 15, 2026

Data Sources Report a data error